MiR-601 inhibited small cell lung cancer progression by modulating SIRT1

被引:3
作者
Ding, Hao [1 ]
Gong, Chenhu [1 ]
Zhang, Zhihong [1 ]
Xu, Hui [1 ]
Ma, Chunping [1 ]
机构
[1] Soochow Univ, Cardiothorac Surg Dept, Affiliated Zhangjiagang Hosp, 68 Jiyang West St, Zhangjiagang 215600, Jiangsu, Peoples R China
关键词
Small cell lung cancer; miR-601; SIRT1; TARGETING SIRT1; MIRNA; PROLIFERATION; MICRORNAS; EXPRESSION; CARCINOMA; REGULATOR; INVASION;
D O I
10.1007/s13273-022-00268-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Dysfunction of microRNAs (miRNAs) contribute to small cell lung cancer (SCLC) progression. Accumulating evidence indicated miR-601, acted as a tumor suppressor gene, has shown an altered expression pattern in multiple cancers. However, little was known about in terms of the function of miR-601 during SCLC progression. Objective Our project intended to illustrate the functions of miR-601 during the development and metastasis of SCLC. Results We found a decreased expression of miR-601 in SCLC tumor tissues and cell lines. Moreover, functional studies suggested that miR-601 overexpression resulted in a reduced cell growth and induced apoptosis of SCLC cells. Notably, sirtuin 1 (SIRT1) was identified as a putative target of miR-601. MiR-601 suppressed SIRT1 expression via interacting with the 3 '-untranslated region (UTR) of SIRT1 in SCLC cells. Also, SIRT1 expression was negatively associated with that of miR-601 in SCLC tissues. The restoration of SIRT1 alleviated the inhibitory effect of miR-601 on SCLC progression. Conclusion Our data documented the tumor-suppressive function of miR-601 in SCLC via targeting SIRT1, suggesting miR-601 as a new potential therapeutic approach for SCLC treatment.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 38 条
  • [1] The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review
    Agrawal, Swati
    Tapmeier, Thomas T.
    Rahmioglu, Nilufer
    Kirtley, Shona
    Zondervan, Krina T.
    Becker, Christian M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [2] Treatment for small cell lung cancer, where are we now?-a review
    Alvarado-Luna, Gabriela
    Morales-Espinosa, Daniela
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 26 - 38
  • [3] The functions of animal microRNAs
    Ambros, V
    [J]. NATURE, 2004, 431 (7006) : 350 - 355
  • [4] MicroRNAs and lipid metabolism
    Aryal, Binod
    Singh, Abhishek K.
    Rotllan, Noemi
    Price, Nathan
    Fernandez-Hernando, Carlos
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2017, 28 (03) : 273 - 280
  • [5] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [6] Identification of miR-601 as a novel regulator in the development of pancreatic cancer
    Cao, Wenxi
    Jin, Huihan
    Zhang, Lei
    Chen, Xiao
    Qian, Haixin
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (01) : 638 - 644
  • [7] Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
    Christou, Niki
    Meyer, Jeremy
    Popeskou, Sotirios
    David, Valentin
    Toso, Christian
    Buchs, Nicolas
    Liot, Emilie
    Robert, Joan
    Ris, Frederic
    Mathonnet, Muriel
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [8] MiRNA Polymorphisms and Cancer Prognosis: A Systematic Review and Meta-Analysis
    Ding, Han-xi
    Lv, Zhi
    Yuan, Yuan
    Xu, Qian
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [9] Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
    Du, Xiaohong
    Zhang, Jitai
    Wang, Juping
    Lin, Xiaoming
    Ding, Feng
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (39) : 5997 - 6010
  • [10] A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression
    Dufresne, Suzanne
    Rebillard, Amelie
    Muti, Paola
    Friedenreich, Christine M.
    Brenner, Darren R.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (01) : 11 - 24